Skip to content

An efficacy and safety of nano fractional radiofrequency for the treatment of striae alba

An efficacy and safety of nano fractional radiofrequency for the treatment of striae alba

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160907003
Enrollment
Unknown
Registered
2016-09-07
Start date
2016-03-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Striae alba Striae alba Fractional radiofrequency Nano fractional RF

Interventions

Nanoneedle fractional radiofrequency (Venus ViVa)
Experimental Device
Nano fractional radiofrequency

Sponsors

Faculty of Medicine, Srinakharinwirot University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: age between 18-60 years, with skin type III or IV were diagnosed with striae alba at thigh, abdominal or buttock area

Exclusion criteria

Exclusion criteria: Subjects who were previously treated with any kind of lasers, RF, dermabrasion, microdermabrasion or chemical peeling within 6 months prior to the study. Subjects who applied topical corticosteroids, retinoid, vitamin C or vitamin E within 3months prior to the study. Subjects who orally took any of the following supplement or medications such as vitamin C, vitamin E, corticosteroids or retinoids within 3 months. Subjects who were heavy tobacco smokers. Subjects who had a history of hypertrophic scar or keloid. Subjects who on pacemaker or have other metallic implants. Subjects who have active skin lesions on the study area.

Design outcomes

Primary

MeasureTime frame
Surface area 12 weeks Pictzar software

Secondary

MeasureTime frame
Width 12 weeks Caliper,Length 12 weeks Caliper

Countries

Thailand

Contacts

Public ContactNapatthaorn Pongsrihadulchai

Skin center, Srinakharinwirot university

Npatthp@gmail.com+66-2-2594260

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026